Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Feb 14:16:1539848.
doi: 10.3389/fimmu.2025.1539848. eCollection 2025.

Disruption of the moonlighting function of CTF18 in a patient with T-lymphopenia

Affiliations
Case Reports

Disruption of the moonlighting function of CTF18 in a patient with T-lymphopenia

Robert Sertori et al. Front Immunol. .

Abstract

Introduction: Newborn screening for immunodeficiency has led to the identification of numerous cases for which the causal etiology is unknown.

Methods: Here we report the diagnosis of T lymphopenia of unknown etiology in a male proband. Whole exome sequencing (WES) was employed to nominate candidate variants, which were then analyzed functionally in zebrafish and in mice bearing orthologous mutations.

Results: WES revealed missense mutations in CHTF18 that were inherited in an autosomal recessive manner. CTF18, encoded by the CHTF18 gene, is a component of a secondary clamp loader, which is primarily thought to function by promoting DNA replication. We determined that the patient's variants in CHTF18 (CTF18 R751W and E851Q) were damaging to function and severely attenuated the capacity of CTF18 to support hematopoiesis and lymphoid development, strongly suggesting that they were responsible for his T lymphopenia; however, the function of CTF18 appeared to be unrelated to its role as a clamp loader. DNA-damage, expected when replication is impaired, was not evident by expression profiling in murine Chtf18 mutant hematopoietic stem and progenitor cells (HSPC), nor was development of Ctf18-deficient progenitors rescued by p53 loss. Instead, we observed an expression signature suggesting disruption of HSPC positioning and migration. Indeed, the positioning of HSPC in ctf18 morphant zebrafish embryos was perturbed, suggesting that HSPC function was impaired through disrupted positioning in hematopoietic organs.

Discussion: Accordingly, we propose that T lymphopenia in our patient resulted from disturbed cell-cell contacts and migration of HSPC, caused by a non-canonical function of CHTF18 in regulating gene expression.

Keywords: CHTF18; T lymphocyte; immunodeficiency; thymus; zebrafish.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Sequence analysis of the parent and proband CHTF18 alleles. NextGen sequence traces of the paternal, maternal, and proband CHTF18 alleles are depicted, with the sequence variants boxed in white.
Figure 2
Figure 2
Structural analysis of CHTF18 patient variants. (A) The structure of human CTF18 is schematized with the structural domains and the location of variants inherited from the mother and father indicated above and below the diagram, respectively (52). NLS, nuclear localization signal; Pro, proline-rich domain; Ank, ankyrin repeat domain; TBD, triple barrel domain in red where CTF18 interacts with DSCC1 and CTF8 (53). (B-E) Clamp loader interface of either RFC1 or CTF18 with RFC3. (B) RFC1 structure (PDB #6VVO) shown in blue cylinders for helices and RFC3 in green. The ADP molecule (displayed with pink carbon atoms) bound by RFC3 is shown in ball-and-stick representation, and the key residues RFC1-986 and RFC3-R9 are labeled. (C) AF3 model of CTF18 (gold; residues 583-863) bound to RFC3. The wildtype R751 makes contact with RFC3-R9 in a similar manner compared to RFC1-R986. (D) AF3 model of the R751W variant makes more extensive contacts with RFC3-R9, changing the RFC-R9 rotamer conformation to where it makes 4 hydrogen bonds with RFC-D6 and the 3’ hydroxyl of ADP. (E) AF3 model of the CTF18-E851Q variant in a solvent exposed location distal from the RFC3 interface.
Figure 3
Figure 3
CHTF18 patient variants fail to support T cell development. (A) Effect of chtf18 knockdown on T cell development at 5 days post fertilization (dpf) in zebrafish embryos. T cell development was assessed by whole-mount in situ hybridization (WISH) using a probe for the T cell specific kinase, lck. Numbers on images represent the fractions of embryos with the depicted phenotype. Thymus is indicated by dashed blue ovals. (right panel) The efficacy of chtf18 E2I2 splice-blocking MO (1ng) was assessed by RT-PCR at 1 dpf. (B) Capacity of patient CHTF18 variants to rescue T cell development in zebrafish. Lateral images of zebrafish treated with control or chtf18 MO and subjected to rescue by heat-induced re-expression of the WT or mutant human CHTF18 orthologs. Rescue of T-cell development was evaluated by lck WISH at 5 dpf. Thymus staining is indicated by dashed blue ovals and the fraction of embryos with the depicted phenotype is indicated on each micrograph. The intensity of the lck WISH signal was quantified by ImageJ software and is depicted graphically as box and whisker plots. Statistical significance was evaluated using one way ANOVA. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 4
Figure 4
Phenotype of Chtf18 mutant mice. (A-C) Flow cytometric analysis of lymphoid development assessed by flow cytometry on thymus (A) and spleen (B, C). Flow cytometry analysis was performed on explanted thymus and spleen from adult WT (+/+) and Cht18 mut (R745W/E845Q) mice using the indicated antibodies to define the following populations in: (A) Thymus: CD4-CD8- (DN), CD4+CD8+ (DP), CD4+ (4SP), CD8 (8SP); (B) Spleen: B220+ (B cells); Thy1+ (T cells), CD4+, CD8+; (C) CD44+CD62L+ (effector memory); CD44+CD62L- (central memory). Absolute numbers of the indicated populations were depicted graphically as scatter plots with each symbol representing an individual animal. Statistical significance as assessed by multiple unpaired t tests.
Figure 5
Figure 5
Assessment of Chtf18 mut HSPC by competitive transplantation. (A, B) The ability of adult Chtf18 mut bone marrow HSPC to repopulate hematopoiesis was assessed by competitive transplantation using allotype marked (CD45.1) competitor. 100,000 Lineage HSPC from CD45.2 WT or Chtf18 mut mice were mixed with an equal quantity of CD45.1 competitor cells and transferred into irradiated recipients. After 6 weeks, the hematopoietic reconstitution was assessed on explanted thymus (A) and spleen (B) cell suspensions by flow cytometry using anti-CD45.1 and anti-CD45.2 antibodies. Cell frequencies were displayed graphically as scatter plots. Statistical significance was assessed by multiple unpaired t tests. (C) The capacity of CD45.2 WT and Chtf18 mut HSPC to home to the bone marrow was assessed as above expect that bone marrow seeding was measured by flow cytometry 4 days after transfer. The number of transferred cells found in the recipient bone marrow was exhibited by scatter plot. Statistical significance was assessed by multiple unpaired t tests.
Figure 6
Figure 6
scRNA-Seq analysis of WT and Chtf18 mut HSPC. (A) Uniform Manifold Approximation Projection (UMAP) plots showing eight distinct HSPC clusters and their relative frequencies in Lineage- HSPC from Chtf18 wildtype and mut mice. (B) Gene Set Enrichment analysis (EnrichGo) of the highly variable expressed genes between Chtf18 wildtype and mut HSC/MPP cluster. (C) Bubble plot representation showing expression of DNA clamp loader proteins and top upregulated genes in the Chtf18 mut HSPCs. (D) Percentage of cells in G1, G2/M and S phase in Chtf18 WT and mut HSPCs. Reference cell type abbreviations: LT-34F, CD34+ Long-term reconstituting stem cell; LT-HSC, CD34- Long-term reconstituting stem cell; MEP, Megakaryocyte-Erythroid Progenitor; CMP, Common Myeloid Progenitor; GMP, Granulocyte-Monocyte Progenitor; MLP, Multilineage Progenitor; HSC/MPP, Hematopoietic Stem Cell and Multi-Potent Progenitor; CLP, Common Lymphoid Progenitor; MDP, Monocyte-Dendritic cell Progenitor; CDP, Common Dendritic cell Progenitor.
Figure 7
Figure 7
Impact of Chtf18 variants on HSPC migration. (A) Gene Set Enrichment analysis (EnrichGo) of the highly variable expressed genes between Chtf18 WT and mut CLP cluster (upper panel). (Bottom Panel) Volcano plot of the top differentially expressed genes between Chtf18 WT and mut CLP cluster. (B) The impact of Ctf18 loss on the localization of HSPC in zebrafish embryos was examined by MO knockdown of chtf18 (chtf18e6), following which the location of HSPC in the caudal hematopoietic tissue was assessed by WISH using a probe for runx1. Statistical significance was assessed by Fisher’s Exact Test, with the p=6.8x10-7 for Con. vs Ctfe6.

Similar articles

References

    1. Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. . Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. Jama. (2014) 312:729–38. doi: 10.1001/jama.2014.9132 - DOI - PMC - PubMed
    1. Currier R, Puck JM. SCID newborn screening: What we’ve learned. J Allergy Clin Immunol. (2021) 147:417–26. doi: 10.1016/j.jaci.2020.1010.1020 - DOI - PMC - PubMed
    1. Dvorak CC, Haddad E, Heimall J, Dunn E, Buckley RH, Kohn DB, et al. . The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J Allergy Clin Immunol. (2023) 151:539–46. doi: 10.1016/j.jaci.2022.1010.1022 - DOI - PMC - PubMed
    1. Thakar MS, Logan BR, Puck JM, Dunn EA, Buckley RH, Cowan MJ, et al. . Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet. (2023) 402:129–40. doi: 10.1016/S0140-6736(1023)00731-00736 - DOI - PMC - PubMed
    1. Forlanini F, Chan A, Dara J, Dvorak CC, Cowan MJ, Puck JM, et al. . Impact of genetic diagnosis on the outcome of hematopoietic stem cell transplant in primary immunodeficiency disorders. J Clin Immunol. (2023) 43:636–46. doi: 10.1007/s10875-10022-01403-10875 - DOI - PMC - PubMed

Publication types